During the past decade, New Haven Clinical Research Unit conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 12 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 4 clinical trials were completed. i.e. 10.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Haven Clinical Research Unit" #1 sponsor was "Pfizer" with 85 trials, followed by "Biogen" with 3 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored, "Catalyst Biosciences" with 1 trials sponsored and "National Institutes of Health Clinical Center (CC)" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Haven Clinical Research Unit" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Pierre Fabre Laboratories" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "New Haven Clinical Research Unit" are "Healthy" (48 trials), "Healthy Volunteers" (10 trials), "Healthy Participants" (8 trials), "Healthy Subjects" (6 trials) and "Bioavailability" (2 trials). Many other conditions were trialed in "New Haven Clinical Research Unit" in a lesser frequency.

Most popular intervention types in "New Haven Clinical Research Unit" are "Drug" (84 trials), "Biological" (9 trials), "Other" (7 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "PF-07321332/ritonavir" (4 trials), "Itraconazole" (3 trials), "Moxifloxacin" (3 trials) and "PF-06372865" (3 trials). Other intervention names were less common.

The vast majority of trials in "New Haven Clinical Research Unit" are 88 trials for "All" genders, 5 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New Haven Clinical Research Unit". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in New Haven Clinical Research Unit, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New Haven Clinical Research Unit, 89 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".